col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Association for Cancer Research

509 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Cancer Research 2024―Jan―16 Abstract A013: Uptake and predictors of Covid-19 vaccination among United States’ cancer populations Tayla Greene, Kikelomo Olaosebikan, Osahon Idolor, James Appiah-Pippim
2 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―21 SARS-CoV-2 Infection and Related Hospitalization Among Cancer Survivors Larissa L. White, Andrea N. Burnett-Hartman, Laura E. Ichikawa, Shauna R. Goldberg, Jessica Chubak, Heather Spencer Feigelson, Aruna Kamineni
3 [GO] Molecular Cancer Research 2023―Dec―08 Single-cell transcriptomics reveals pre-existing COVID-19 vulnerability factors in lung cancer patients Wendao Liu, Wenbo Li, Zhongming Zhao
4 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract C127: Strategies to improve breast cancer screenings among uninsured individuals post COVID-19 Evelyn Robles-Rodriguez, Plyshette Wiggins, Tondalya DeShields
5 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract B024: Engaging rural male cancer survivors during COVID-19 Jala Lockhart, Levi Ross, Vanessa B. Sheppard, Michael A. Preston
6 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract A008: Addressing medical distrust among African Americans and adherence to cancer screening recommendations during COVID-19 Finie Hunter-Richardson, Pamela L. Carter-Nolan, Carla D. Williams, Mark S. Johnson
7 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract C129: Impact of COVID-19 on colorectal cancer screening disparities: Results from a large commercially insured population in the United States Arfan Siddique, Rong Wang, Jacquelyne Gaddy, Cary Gross, Xiaomei Ma
8 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract A108: Perceived negative effects of COVID-19 on mental health based on a history of cancer Meng Chen, Dina K. Abouelella, Melissa C. White, Rong Jiang, Oluwole A. Babtunde, Eric Adjei Boakye, et al. (+2)
9 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract A095: Rural disparities in telemedicine use among cancer survivors during the COVID-19 pandemic Minjee Lee, Meng-Han Tsai
10 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract B045: Effect of the COVID-19 pandemic on disparities in stage of breast cancer diagnosis Ruvarashe P. Rumano, Nicci Owusu-Brackett, Akia Clarke, Robert Tamer, Elizabeth Ghias, Jesse Plascak, et al. (+2)
11 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract B129: The association of Covid-19 pandemic restrictions with patient-reported outcomes and lifestyle behaviors among breast cancer survivors: Evidence from a cohort of Black and Hispanic breast cancer survivors in New Jersey Carola T. Sanchez-Diaz, Nur Zeinomar, Hari S. Iyer, Marley Perlstein, Chi-Chen Hong, Bo Qin, Elisa V. Bandera
12 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Dec―01 Abstract C131: Disparities in breast cancer screening resumption among health plan enrollees in the US following the COVID-19 pandemic: Are all groups back on track? Jennifer Tsui, Sarah Axeen, John Thacker, Sonali Saluja, Laura Solano, Willow Pastard, et al. (+3)
13 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Aug―18 Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries Amina Chtourou, Pamela V. Sanchez, Todd Golden, Huann-Sheng Chen, Stephen M. Schwartz, Xiao-Cheng Wu, et al. (+4)
14 [GO] Cancer Research 2023―Jun―09 Abstract 5523: Impact of COVID-19 on longitudinal breast cancer research studies involving TNBC patients Cherie Bates, Esther Kong, Elena Zaikova, Samuel Aparicio, Karen Gelmon
15 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 80: The Impact of Covid-19 Pandemic in Colonoscopies and Colorectal, Rectosigmoid and Anal Cancer Screening Rafaela de Andrade, Gabriele Eckerdt Lech, Pedro Antonio Paludo Menna Barreto, Arthur Minas Alberti, Luiza Seixas de Sá Beltramo, Fernando Azambuja, et al. (+3)
16 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 79: The Impact of COVID-19 on HPV Immunization Programs in Countries With High Cervical Cancer Burdens: Global and National Perspectives Dominique Guillaume, Due-e-Nayab Waheed, Mieke Schlieff, Kirthini Muralidharan, Alex Vorsters, Rupali Limaye
17 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 51: Impacts of the COVID-19 Pandemic on Pediatric and Adolescent Cancer Care in Northern Tanzania Hannah Rice, Esther Majaliwa, Cesia Cotache-Condor, Yotham Gwanika, Nelson Chao, Kristin Schroeder, et al. (+4)
18 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 50: Impact of the COVID-19 Pandemic on Breast Cancer Treatments in the Brazilian Public System Laura Tibola Marques da Silva, Pedro Antonio Paludo Menna Barreto, Luiza Seixas de Sá Beltramo, Gabriele Eckerdt Lech, Fernando Azambuja, Rafaela de Andrade, et al. (+3)
19 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 45: How Did States Adapt Their Cancer Control Plan During the COVID-19 Pandemic? Jason Semprini
20 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jun―01 Abstract 68: Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative Sok King Ong, Laureline Gatellier, Tomohiro Matsuda
21 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―May―02 Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States, with a Focus on Changes During the COVID-19 Pandemic Jessica Star, Priti Bandi, Nigar Nargis, Farhad Islami, K Robin Yabroff, Adair K. Minihan, et al. (+2)
22 [GO] Blood Cancer Discovery 2023―Apr―20 Defective Immunity Against SARS-CoV-2 Omicron Variants Despite Full Vaccination in Hematologic Malignancies Laurence Zitvogel, Lisa Derosa, Guido Kroemer
23 [GO] Cancer Research 2023―Apr―14 Abstract LB054: Establishment of an infrastructure for rapid pandemic response at the Frederick National Laboratory Nancy V. Roche, Troy Kemp, Ligia Pinto, Tom Hickey
24 [GO] Cancer Research 2023―Apr―05 Abstract 5590: Liquid biopsy testing in metastatic or advanced breast cancer patients during the COVID-19 pandemic Benjamin L. Furman, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, et al. (+5)
25 [GO] Cancer Research 2023―Apr―04 Abstract 794: Repurposing of poly-γ-glutamic acid, immunotherapeutic drug for cervical intraepithelial neoplasia 1, as covid-19 treatment Chan-Hee Yoo, Jae Chul Choi, Do Young Lee, Chun-Soo Lee, Young-Chul Park
26 [GO] Cancer Research 2023―Apr―04 Abstract 795: T-cell mediated response to emerging COVID-19 strains in patients with cancer studied via deep learning Olga Lyudovyk, Yuval Elhanati, Artem Streltsov, Quaid Morris, Santosha Vardhana, Benjamin Greenbaum
27 [GO] Cancer Research 2023―Apr―04 Abstract 799: Measuring the impact of the COVID-19 pandemic on breast cancer screening in Puerto Rico Vivian Colón-López, Hermilis Berrios Ortiz, Hector Contreras-Mora, Orville M. Disdier, Cynthia M. Pérez, Nilda Ríos, et al. (+3)
28 [GO] Cancer Research 2023―Apr―04 Abstract 800: Participation in COVID-19 clinical trials, willingness to participate, and trust in sources of information among persons with and without cancer in Puerto Rico.   Fabiola A. Rivera-Gastón, Hérmilis Berríos-Ortiz, Jeslie M. Ramos-Cartagena, Andrea López-Cepero, Vivian Colón-López, Cynthia M. Pérez, Ana P. Ortiz
29 [GO] Cancer Research 2023―Apr―04 Abstract 801: The impact of COVID-19 on colorectal screening in Puerto Rico Héctor M. Contreras-Mora, Erick L. Suárez-Pérez, Cynthia M. Pérez, Hérmilis Berríos-Ortiz, Orville M. Disdier, Nilda Ríos, et al. (+3)
30 [GO] Cancer Research 2023―Apr―04 Abstract 806: Enhancer deregulation inTET2-mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality Moritz Binder, Terra L. Lasho, Wazim Mohammed Ismail, Nana A. Ben-Crentsil, Jenna A. Fernandez, Minsuk Kim, et al. (+20)
31 [GO] Cancer Research 2023―Apr―04 Abstract 797: COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors Danielle Gilbert, Junxiao Hu, Elaine T. Lam
32 [GO] Cancer Research 2023―Apr―04 Abstract 804: The temporal evolution in disease phenotype of COVID-19 hospitalisation, intensive care and case fatality rates in cancer patients across the United Kingdom (UKCCP) Thomas Starkey, Maria C. Ionescu, Matthew W. Fittall, Michael Tilby, Alex Burnett, Rosie Hattersley, et al. (+11)
33 [GO] Cancer Research 2023―Apr―04 Abstract 805: Association of state-level COVID-19 mortality rates with real-world progression and real-world overall survival among patients with advanced non-small cell lung cancer, 2020-2022 Maneet Kaur, Christina M. Parrinello, Jenny S. Guadamuz, Trevor J. Royce, Gregory S. Calip
34 [GO] Cancer Research 2023―Apr―04 Abstract 807: Inflammatory biomarkers: Breast cancer survival and possible role in COVID-19 associated comorbidity Alakesh Bera, Eric Russ, Surya Radhakrishnan, Hai Hu, COL Craig D. Shriver, Meera Srivastava
35 [GO] Cancer Research 2023―Apr―04 Abstract 787: Lung cancer screening use before & during the COVID-19 pandemic in the US: Population-based evidence from 2019-2021 Hermine Poghosyan, Sayantani Sarkar, Ilana Richman
36 [GO] Cancer Research 2023―Apr―04 Abstract 792: SARS-CoV-2 spike S1 mediated lung tumor regression in a mouse model Monica Sheinin, Kalipada Pahan, Ramesh K. Paidi
37 [GO] Cancer Research 2023―Apr―04 Abstract 802: Identifying factors that affect barriers to lymphoma treatment during the COVID - 19 pandemic Cherie D. Bates, Steve E. Kalloger, Lorna E. Warwick
38 [GO] Cancer Research 2023―Mar―02 Abstract P3-03-11: Racial and Ethnic Disparities in Screening Mammography During COVID-19 Arissa Milton, Ryan Woods, Mai Elezaby, Kelly Hackett, Joan Neuner, Anand Narayan, Roberta Strigel
39 [GO] Cancer Research 2023―Mar―02 Abstract P4-03-36: Determinants of severe COVID-19 infection in Patients with Breast Cancer from a Community Oncology Practice in Brazil Fanny Cascelli, Matheus Costa e Silva, Rodrigo Dienstmann, Bruno L. Ferrari, Carlos Gil Ferreira, Max S. Mano, et al. (+4)
40 [GO] Cancer Research 2023―Mar―02 Abstract P1-05-20: COVID-19 Lockdown Resulting in Advanced Cancer and Worse Histology at Presentation in Hispanics Juzar Hussain, Gabriel Roman Souza, Tamarah Aldawoodi, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
41 [GO] Cancer Research 2023―Mar―02 Abstract P6-05-13: The Psychological Impacts of COVID-19 on Breast Cancer Patients in China Yijia Wang, Yuqing Yang, Changjiao Yan, Jixin Yang, Hongliang Wei, Wen Ma, Nanlin Li
42 [GO] Cancer Research 2023―Mar―02 Abstract P4-03-25: Patient-level predictors of skipping screening mammograms during the COVID-19 pandemic at a large tertiary care center in Texas Maryam Nemati Shafaee, Omar Rosales, Randall Parker Kirby, Tamara Ortiz-Perez, Luke Gilman, Ashley Hardeman, et al. (+3)
43 [GO] Cancer Research 2023―Mar―02 Abstract P1-05-22: The Impact of the COVID-19 Pandemic on Breast Cancer Diagnoses in San Antonio, TX Gabriel Roman Souza, Tamarah Aldawoodi, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
44 [GO] Cancer Research 2023―Mar―02 Abstract P4-03-29: Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway Anouk Eijkelboom, Linda de Munck, Marthe Larsen, Jan Nygård, Solveig Hofvind, Sabine Siesling
45 [GO] Cancer Research 2023―Mar―02 Abstract P1-05-19: Impact of the COVID-19 pandemic on the diagnostic pathway of breast cancer in the Netherlands: a population-based study Wouter Wolfkamp, Joyce Meijer, Jolanda Van Hoeve, Jeroen Veltman, Sabine Siesling
46 [GO] Cancer Research 2023―Mar―02 Abstract P1-05-21: Change in breast cancer detection method, stage at diagnosis and treatment during the COVID-19 Pandemic: 2019-2021 Judith A. Malmgren, Mary Atwood, Henry Kaplan
47 [GO] Cancer Research 2023―Mar―02 Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment Brian Egleston, Mary Daly, Kaitlyn Lew, Lisa Bealin, Alexander Husband, Jill Stopfer, et al. (+5)
48 [GO] Cancer Research 2023―Mar―02 Abstract P6-08-07: Reasons for Reduced Willingness to Participate in Clinical Trials During the COVID-19 Pandemic: The Translational Breast Cancer Research Consortium (TBCRC) 057 Survey Karen L. Smith, Carolyn Mead-Harvey, Gina L. Mazza, Albert E. Holler, Eileen Shinn, Elizabeth Frank, et al. (+7)
49 [GO] Cancer Research 2023―Mar―02 Abstract P1-12-04: Side Effects of the mRNA COVID-19 Vaccines in Women Treated for Breast Cancer Brooke Juhel, Cheryl L. Brunelle, Madison C. Bernstein, Louisa H. Smith, Amanda W. Jung, Elizabeth K. Hausman, et al. (+3)
50 [GO] Cancer Research 2023―Mar―02 Abstract P6-05-19: Racial Disparities in the Quality of Life and Vaccination of Breast Cancer Survivors during COVID-19: A Longitudinal Study Fangyuan Zhao, Brenda L. Copley, Sondra H. Birch, Rita Nanda, Olufunmilayo I. Olopade, Dezheng Huo
51 [GO] Cancer Research 2023―Mar―02 Abstract P3-03-04: Cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer during the COVID pandemic period: efficacy in relation to vaccination for SARS-COV 19 Filippo Giovanardi, Edoardo Carretto, Giancarlo Bisagni, Claudia Degli Esposti, Elisa Gasparini, Alessandra Bologna, et al. (+3)
52 [GO] Cancer Research 2023―Mar―02 Abstract P1-06-06: Access to medical coverage in newly diagnosed Breast cancer patients a minority population during the COVID 19 pandemic Tamarah Aldawoodi, Gabriel Roman Souza, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
53 [GO] Cancer Research 2023―Mar―02 Abstract P6-05-45: Providing Educational Resources during the Pandemic for Advanced Breast Cancer Patients Ginny T. Kirklin, Abbey Kaler, Debu Tripathy
54 [GO] Cancer Research 2023―Mar―02 Abstract P3-03-01: The impact of the COVID19 pandemic on treatment practices for patients diagnosed with early breast cancer: a cross-sectional study from a large comprehensive cancer centre in Italy Fabio Girardi, Sabrina Marini, Francesca Porra, Ilaria Mietto, Sonia Carpentieri, Alberto Marchet, et al. (+11)
55 [GO] Cancer Research 2023―Mar―02 Abstract P6-05-51: Best Quality of Care from a Distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, patient participation and satisfaction with the program Gretchen Kimmick, Smrithi Divakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
56 [GO] Cancer Research 2023―Mar―02 Abstract P6-08-13: Home-based treatment with subcutaneous (SC) trastuzumab - only a pandemic solution? Real world evidence (RWE) analysis Barbara Radecka, Hudała-Klecha Joanna, Dariusz Sawka, Jolanta Sarga, Bożena Noworolska, Jolanta Sawicka, et al. (+3)
57 [GO] Cancer Research 2023―Mar―02 Abstract P4-05-03: Investigating Financial Toxicity among Breast Cancer Patients Diagnosed during the Pandemic: The Role of Cancer Care Disruptions and Social Isolation Chiara Acquati, Tzuan Chen, Isabel Martinez Leal, Shahnjayla Connors, Anastasia Rogova, Mathew Banegas, et al. (+3)
58 [GO] Cancer Research Communications 2023―Jan―26 MEASURING THE IMPACT OF THE COVID-19 PANDEMIC ON HEALTH BEHAVIORS AND HEALTHCARE UTILIZATION IN RURAL AND URBAN CANCER PATIENTS AND CANCER SURVIVORS Alison Cole, C. Holly A. Andrilla, Davis G Patterson, Sarah Davidson, Jason A Mendoza
59 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―10 COVID-19 outcomes by cancer status, site, treatment, and vaccination Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh. Pearce, Christopher R. Friese, et al. (+2)
60 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B123: Prevalence of COVID-19 among hematology/oncology patients and providers of a community-facing county health system during the B1.1.529 (“Omicron”) SARS-CoV-2 variant wave Aliya Khan, Samuel A. Kareff, Priscila Barreto-Coelho, Sunil Iyer, Brian Pico, Michele Stanchina, et al. (+4)
61 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B020: “Access to these screenings have been a gift”: A mixed methods assessment of a community navigation program for breast and cervical in the era of COVID-19 Leslie R. Carnahan, Chibuzor Abalsalim, Jeanette Santana González, Mari Goudy, Hunter Holt, Jessica Madrigal, et al. (+7)
62 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study Pamela C. Egan, Chinmay Jani, Harpreet Singh, Sanjay Mishra, Jeremy L. Warner
63 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract C130: Cervical, breast, and colorectal cancer screening by COVID-19 booster and influenza vaccination status in a sample of women in Puerto Rico Katherine A. Hill, Cynthia M. Pérez, Adriana Pons, Karelys Canales Birriel, Andrea López Cepero, Norangelys Solís Torres, et al. (+2)
64 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B024: Pivot to SPARCC diversity in the clinical cancer research workforce; implementation and evaluation of an academic enrichment pathway before, during, and after the COVID-19 global pandemic Kristina Kaljo, Lindsey McAlarnen, Michael Braun, Emmanuel Ngui, Janet S. Rader
65 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract C103: Inequities in timely cancer treatment after testing positive for COVID-19: Findings from the ASCO Survey on COVID-19 in Oncology (ASCO) Registry Adana A.M. Llanos, Adiba Ashrafi, Nabarun Ghosh, Jennifer Tsui, Yong Lin, Angela J. Fong, et al. (+2)
66 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B087: Disparities in pediatric patients receiving proton therapy during the COVID-19 pandemic - A single institutional experience Samuel P. McKinnon, Zara I. Kazmierczak, Arthur J. Olch, Daniel Roh, Ethan Nguyen, Kristen Pang, et al. (+2)
67 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B060: Increasing breast and cervical cancer knowledge in the COVID-19 pandemic in the health system Omayra Salgado-Cruz, Nelybeth Santiago-Yance, Mirza Rivera-Lugo, Guillermo Tortolero-Luna
68 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract A053: Assessing the impact of the COVID-19 pandemic on a statewide breast and cervical cancer safety net screening and diagnostic program: Are there differences by rural - urban geography? Leslie R. Carnahan, Ananya Stoller, William Barshop, Genevieve Rizzo, Arden Handler
69 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract A096: Stakeholders’ perceptions on the impact of the COVID-19 pandemic on the implementation of the HPV vaccine school-entry requirement in Puerto Rico Coralia Vázquez-Otero, Diana T. Medina-Laabes, Derick Pérez-Guzmán, Olga L. Díaz-Miranda, VOCES PR, Vivian Colón-Lopez
70 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract B037: Effective recruitment strategies utilized in the midst of a COVID-19 pandemic to examine dietary practices and colorectal cancer screening practices of Blacks in New York City Cicely K. Johnson, Grace X. Ma, May May Leung, Olorunseun O. Ogunwobi
71 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract A090: Overcoming racial and ethnic disparities in cancer clinical trial accrual during the COVID-19 pandemic: A partnership between a cancer center’s clinical trials office and community outreach and engagement Jesse Nodora
72 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract A025: HPV and COVID-19 vaccines attitudes and preferred sources of information among adults living in Puerto Rico Jessica N. Rivera-Rivera, Olga L. Díaz-Miranda, Diana T. Medina-Laabes, Erick Suárez, Ana P. Ortiz, Vivian Colón-López
73 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract C120: Are there racial disparities in the incidence of venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19? Adnan Khan, Chun-Hui Lin, Sheela Tejwani
74 [GO] Cancer Epidemiology Biomarkers & Prevention 2023―Jan―09 Abstract A048: Pandemic effects on social capital and loneliness in residents and non-residents of Chinese immigrant enclaves in Philadelphia Marilyn Tseng, Brian Egleston, Julia Zhong, Minzi Li, Carolyn Fang
75 [GO] Cancer Prevention Research 2023―Jan―04 Abstract P019: Continued depression of breast and lung cancer screening among Medicare enrollees during the COVID-19 pandemic Christopher Huy D. Doan, Shuang Li, James Goodwin
76 [GO] Blood Cancer Discovery 2022―Dec―13 Impaired SARS-CoV-2 variant neutralization and CD8+ T cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, et al. (+22)
77 [GO] Cancer Research Communications 2022―Dec―13 Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies Andres Chang, Akil Akhtar, Lilin Lai, Victor M Orellana-Noia, Susanne L Linderman, Ashley A McCook-Veal, et al. (+20)
78 [GO] Cancer Immunology Research 2022―Dec―02 Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2 Chrysovalantis Voutouri, Corey C Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F Gainor, et al. (+3)
79 [GO] Cancer Research 2022―Dec―02 Abstract A019: Impact of COVID-19 on patient navigation services for follow-up colonoscopy after abnormal fecal testing in community health centers Jamie H. Thompson, Jennifer Rivelli, Jennifer Schneider, Amanda F. Petrik, Gloria D. Coronado
80 [GO] Cancer Research 2022―Nov―15 Abstract A048: Impact of COVID-19 on pancreatic cancer outcomes in Florida Guettchina Telisnor, Alexander S. Lim, Zhongyue Zhang, XiangYang Lou, Ibrahim Nassour, Bo Han, et al. (+2)
81 [GO] Clinical Cancer Research 2022―Nov―07 Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, et al. (+16)
82 [GO] Cancer Research Communications 2022―Nov―01 Boosting of waned humoral and cellular responses to SARS-CoV-2 variants-of-concern among cancer patients Duncan R McKenzie, Rosalind Graham, Thomas Lechmere, Clara Domingo-Vila, Thanussuyah Alaguthurai, Celeste Arman, et al. (+13)
83 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Oct―10 Impact and recovery from COVID-19-related disruptions in colorectal cancer screening and care in the US: A scenario analysis Rosita van den Puttelaar, Iris Lansdorp-Vogelaar, Anne I. Hahn, Carolyn M. Rutter, Theodore R. Levin, Ann G. Zauber, Reinier G S. Meester
84 [GO] Blood Cancer Discovery 2022―Sep―08 Anti-spike T cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with hematologic malignancies Lee M. Greenberger, Larry A. Saltzman, Lore M. Gruenbaum, Jun Xu, Sneha T. Reddy, Jonathon W. Senefeld, et al. (+5)
85 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Aug―15 Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin Margaret B. Nolan, Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, Michael C. Fiore, Robert T. Adsit, et al. (+46)
86 [GO] Cancer Research 2022―Jun―15 Abstract 435: COVID-19 & cancer prevention in Texas: Reasons cited for HPV vaccination hesitancy and refusal during the pandemic Onyema Chido-Amajuoyi, Mala Pande, Robert Yu, Sanjay Shete
87 [GO] Cancer Research 2022―Jun―15 Abstract 5276: COVID-19 and breast cancer care in Ireland: A qualitative study to explore the perspective of breast cancer patients on their health and health care Charlotte L. Myers, Catherine Waldron, Kathleen Bennett, Caitriona Cahir
88 [GO] Cancer Research 2022―Jun―15 Abstract 3585: Disparities in cancer treatment delays or discontinuation among cancer patients diagnosed with SARS-CoV-2 infection: An analysis of the U.S. ASCO COVID-19 and cancer registry Jessica Yasmine Islam, Cassandra A. Hathaway, Emma Hume, Kea Turner, Julie Hallanger-Johnson, Shelley S. Tworoger, Marlene Camacho-Rivera
89 [GO] Cancer Research 2022―Jun―15 Abstract 2266: Host genetic susceptibility to COVID-19 and pandemic -associated stressors Maria Gonzalez-Pons, Valeria Valentin, Ingrid Montes-Rodriguez, Maria J. Sanchez, Fabiola M. Morales, Ibis R. Vera-Urbina, et al. (+8)
90 [GO] Cancer Research 2022―Jun―15 Abstract 442: Exploring the impact that COVID-19 had on patient distress in a rural cancer center Sierra Silverwood, Kelly Hirko
91 [GO] Cancer Research 2022―Jun―15 Abstract 444: COVID-IRIS: Immune reconstitution after G-CSF administration for neutropenia during acute COVID-19 infection Chloe S. Lalonde, Tony Z. Zhuang, Amalia A. Aldredge, Max W. Adelman, Abeer N. AbouYabis, Morgan L. McLemore, Sara C. Auld
92 [GO] Cancer Research 2022―Jun―15 Abstract 5275: The short-term impact of COVID-19 on lung cancer screening participation and adherence Yannan Lin, William Hsu, Denise R. Aberle, Ashley E. Prosper
93 [GO] Cancer Research 2022―Jun―15 Abstract 441: The impact of the COVID-19 on the screening of breast and cervical cancer in Korea Hyeree Park, Seung Hee Seo, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin
94 [GO] Cancer Research 2022―Jun―15 Abstract 433: Colorectal and gastric cancer screening rates in Korea during the COVID-19 pandemic Seung Hee Seo, Hyeree Park, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin
95 [GO] Cancer Research 2022―Jun―15 Abstract 434: Development of virtual outreach strategies to supply cancer education and prevention information during the COVID-19 pandemic Monica Yellowhair, Desiree Jones, Gabriela Ruiz, Octavio Castanos, Rene D. Herrera, Juan Contreras, et al. (+2)
96 [GO] Cancer Research 2022―Jun―15 Abstract 439: Physical activity among male cancer survivors during the COVID-19 pandemic Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, Lorelei A. Mucci
97 [GO] Cancer Research 2022―Jun―15 Abstract 438: Psychosocial outcomes, sleep, and substance use among male cancer survivors during the COVID-19 pandemic Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, et al. (+2)
98 [GO] Cancer Research 2022―Jun―15 Abstract 440: Diet and supplement use changes among male cancer survivors during the COVID-19 pandemic Alaina H. Shreves, Colleen B. McGrath, Konrad Stopsack, Lilian Cheung, Ann Fisher, Edward Giovannucci, et al. (+3)
99 [GO] Cancer Research 2022―Jun―15 Abstract 2244: Video-based germline testing for individuals with pancreatic ductal adenocarcinoma: Influence of COVID-19 pandemic Saumya Kasliwal, Seyda Baydogan, Devon Harrison, Mark Hurd, Maureen Mork, Anirban Maitra, Florencia McAllister
100 [GO] Cancer Research 2022―Jun―15 Abstract 6231: Predictors of objectively-measured sedentary time during the COVID-19 pandemic among breast cancer survivors participating in a diet and physical activity intervention Sidney Donzella, Chongzhi Di, Eileen Rillamas-Sun, Hanjie Shen, Sofia Cobos, Yuhan Huang, et al. (+4)
101 [GO] Cancer Research 2022―Jun―15 Abstract 6178: COVID-19 pandemic and clinicopathologic characteristics of colorectal cancer in Korea: A multicenter, retrospective study Yoon Dae Han, Jun Sang Shin, Sung Uk Bae, Woo Ram Kim, Dae Ro Lim, Chang Woo Kim
102 [GO] Cancer Research 2022―Jun―15 Abstract 1999: The impact of the COVID-19 pandemic on 30-day survival in pediatric cancer patients in low, middle, and high-income countries: an international, observational cohort study Muhammed Elhadi, Soham Bandyopadhyay, Noel Peter, Kokila Lakhoo
103 [GO] Cancer Research 2022―Jun―15 Abstract 5274: Mechanisms of action (MOA) for proxalutamide, an androgen receptor (AR) antagonist, for the treatment of mild, moderate and severe COVID-19 patients Liandong Ma, Youzhi Tong, Qianxiang Zhou, Hongha Yan, Xiaodan Hou, Zhiha Ren, et al. (+6)
104 [GO] Cancer Research 2022―Jun―15 Abstract 3587: Racial disparity in COVID-19 severity after adjusting for chronic illnesses and sociodemographic factors Xiao-Cheng Wu, Yong Yi, Lauren S. Maniscalco, Mei-Chin Hsieh, DeAnn Gruber, Lee Mendoza, et al. (+3)
105 [GO] Cancer Research 2022―Jun―15 Abstract 3586: Immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CART cell therapy Thierry Iraguha, Saurabh Dahiya, Stephanie Avila, Aaron Rapoport, Tim Luetkens, Djordje Atanackovic
106 [GO] Cancer Research 2022―Jun―15 Abstract 3584: COVID-19 vaccination primary and secondary hesitancy among veterans with cancer in the Arkansas-Louisiana-Texas Region Philip A. Haddad, Dalia Hammoud, Miriam L. Mcgowen, Laura Houston, Monica Craig, Trenesia McCain, et al. (+3)
107 [GO] Cancer Research 2022―Jun―15 Abstract CT258: Interim safety and immunogenicity results of a phase I trial evaluating the multi-peptide COVID-19 vaccine candidate CoVac-1 for induction of SARS-CoV-2 T cell immunity in cancer patients with disease- or treatment-related immunoglobulin deficiency Claudia Tandler, Jonas S. Heitmann, Maddalena Marconato, Yacine Maringer, Monika Denk, Marion Richter, et al. (+6)
108 [GO] Cancer Research 2022―Jun―15 Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET Eva Segelov, Amy Body, Stuart Turville, Corey Smith, Katie Lineburg, Sudha Rao, et al. (+14)
109 [GO] Cancer Research 2022―Jun―15 Abstract 5279: Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review Yun-Ju Lai, Te-An Lee, Shih-Han Wang, Chia-Wei Li, Louise D. McCullough, Dhimiter Bello
110 [GO] Cancer Research 2022―Jun―15 Abstract 5273: The peripheral proinflammatory responses in COVID-19: Clinical spectrum and outcome in patients with and without cancer Amer N. Radwi, Zahra H. Alshardi, Rakan H. Alelyani, Raha M. Garout, Lojain N. Alruwaili, Muhammad T. Bakhsh
111 [GO] Cancer Research 2022―Jun―15 Abstract 446: Outcome of cancer patients with COVID-19: the VCU experience Patrick J. Willard, Temmy Olasehinde, Naji Bou Zeid, Edem Defor, Victor Yazbeck, Dipankar Bandyopadhyay
112 [GO] Cancer Research 2022―Jun―15 Abstract 2056: PI3Kgamma inhibition reduces inflammation and promotes survival in cancer and SARS-CoV-2 Judith A. Varner, Anghesom Ghebremedhin
113 [GO] Cancer Research 2022―Jun―15 Abstract LB226: Requirement for booster doses in healthy, cancer and immunosuppressed patients infected with the ancestral or variant SARS-CoV-2 Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Melin J. Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, et al. (+2)
114 [GO] Cancer Research 2022―Jun―15 Abstract 2937: Mutational analysis of ORF-8 of SARS-CoV-2 - a window to immunotherapy Gopika Trieu, Nikita Mehta, Jeffrey Park, Andrew Ionescu, Lily Asgari, Vuong Trieu
115 [GO] Cancer Research 2022―Jun―15 Abstract 5272: Aberrant DNA 5mC and 6mA methylations increase ACE2 expression in intestinal cancer cells susceptible to SARS-CoV-2 infection Heng Wang, Yumo Xie, Gaopo Xu, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu
116 [GO] Cancer Research 2022―Jun―15 Abstract 4249: Quantitative PBMC ADCC bioassay and ADCC reporter bioassays for immunotherapy and SARS-CoV-2 monoclonal antibody development Pete Stecha, Jun Wang, Denise Garvin, Julia Gilden, Jamison Grailer, Jim Hartnett, et al. (+3)
117 [GO] Cancer Research 2022―Jun―15 Abstract 437: Characterization of SARS-CoV-2 using the Ion AmpliSeq SARS-CoV-2 research panel Desiree Unselt, Katherine Knudsen, Christopher Rounds, Janet Doolittle-Hall, Fernando Torres, Jennifer Sims, Jennifer Mason
118 [GO] Cancer Research 2022―Jun―15 Abstract 5277: Humoral SARS-CoV-2 response in asymptomatic precursor plasma cell dyscrasia patients: IMPACT study results Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Hong Yue, Federico Ferrari, Massimiliano Russo, Robert A. Redd, et al. (+13)
119 [GO] Cancer Research 2022―Jun―15 Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract Eva Segelov, Amy Body, Vi Luong, Veronica Aedo Lopez, Luxi Lal, Hesham Abdulla, et al. (+9)
120 [GO] Cancer Research 2022―Jun―15 Abstract 436: Rapid flow cytometric whole blood assay for assessment of SARS-CoV-2-reactive T cell immunity Lorenz Fülle, Philipp David Gert, Verena Traska, Sofia Chatzopoulou, Christian Dose, Anne Richter, Marc Schuster
121 [GO] Cancer Research 2022―Jun―15 Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Michelle Aranha, Mahshid Rahmat, Ting Wu, Michael Timonian, et al. (+13)
122 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―May―04 Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study Joshua W. Bliss, Jessica A. Lavery, Whitney P. Underwood, Su S. Chun, Gina A. Fickera, Catherine P. Lee, et al. (+8)
123 [GO] Cancer Prevention Research 2022―May―03 Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs Goli Samimi, Margaret House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody, et al. (+8)
124 [GO] Cancer Discovery 2022―May―02 Top COVID-19 Prognostic Factors Identified
125 [GO] Cancer Discovery 2022―Apr―04 Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection Lisa H.F. McGary, Santosha A. Vardhana
126 [GO] Blood Cancer Discovery 2022―Mar―09 Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, et al. (+54)
127 [GO] Cancer Discovery 2022―Mar―09 The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals. Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, et al. (+62)
128 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 Tamara Hamlish, Elizabeth L Papautsky
129 [GO] Cancer Research 2022―Mar―08 Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12)
130 [GO] Cancer Research 2022―Mar―08 Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons
131 [GO] Cancer Research 2022―Mar―08 Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson
132 [GO] Cancer Research 2022―Mar―08 Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4)
133 [GO] Cancer Research 2022―Mar―08 Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4)
134 [GO] Cancer Research 2022―Mar―08 Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12)
135 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
136 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
137 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2)
138 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
139 [GO] Cancer Research 2022―Mar―08 Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6)
140 [GO] Cancer Research 2022―Mar―08 Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2)
141 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5)
142 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk
143 [GO] Cancer Research 2022―Mar―08 Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3)
144 [GO] Cancer Research 2022―Mar―08 Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8)
145 [GO] Cancer Research 2022―Mar―08 Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5)
146 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2)
147 [GO] Cancer Research 2022―Mar―08 Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4)
148 [GO] Cancer Research 2022―Mar―08 Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro
149 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4)
150 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3)
151 [GO] Cancer Research 2022―Mar―08 Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19)
152 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11)
153 [GO] Cancer Research 2022―Mar―08 Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7)
154 [GO] Cancer Research 2022―Mar―08 Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
155 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study Chandralekha Krishnan
156 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli
157 [GO] Cancer Research 2022―Mar―08 Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari
158 [GO] Clinical Cancer Research 2022―Feb―09 AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta
159 [GO] Cancer Immunology Research 2022―Jan―24 Immune-guided therapy of COVID-19 Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, et al. (+2)
160 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-108: Predictors of retention rates in the Active Living After Cancer program at MD Anderson Cancer Center: A comparison of classes during and before COVID-19 Kendahl Servino, Stacy Mitchell, Che Young Lee, Yue Liao, Karen Basen-Engquist
161 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-056: The ReTOOL training program for underrepresented minority students: Best practices for virtual training in midst of COVID-19 Parisa Fathi, Folakemi Odedina, John Allen, Debra Lyon, Diana Wilkie, Nissa Askins, Brian Seymour
162 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-017: The association of COVID-19 and cancer screening inquiries among Spanish speakers: An examination of NCI Cancer Information Service data Heather N. Platter, Adaora Ezeani, Travis Hyams, Grace C. Huang, Robin C. Vanderpool, William M.P. Klein
163 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-075: COVID-19 and social determinants of health (SDOH): Impact on cancer prevention in GENZ population (Ages 18-25) Beth A. Jones, Sakinah C. Suttiratana, Shua Kim, William Eger
164 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-125: Mental health symptoms during the COVID-19 pandemic among cancer survivors who endorse cannabis: Results from the COVID-19 cannabis health study Diane L. Rodriguez, Denise C. Vidot, Marlene Camacho-Rivera, Jessica Y. Islam
165 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-115: Defining radiation treatment quality disparities in the COVID-19 Era Elizabeth C. Gaudio, Nariman Ammar, Daniel V Wakefield, Maria Pisu, Arash Shaban-Nejad, David L Schwartz
166 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-122: Palliative care for 317 cancer patients with COVID-19 in a major public hospital in South America Tulio L. Correa, Joyce V.B. Sobreira, Áurea M.S. Simão, Fernanda B. Anbar, Flavia Yarshell, Ricardo T. de Carvalho
167 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-041: The impact of COVID-19 on cancer care in the Latinx community in Northern California: A mixed method community-engaged research study Patricia Rodriguez Espinosa, Darcie Green, Yessica Martinez Mulet, Miriam L. Trigo, Natalia M. Zamora Zeledon, Eric Meléndez, Lisa G. Rosas
168 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-253: Overcoming barriers to colorectal cancer screening for underserved patients: Lessons from the COVID-19 pandemic Kathryn M. Glaser, Christina Crabtree-Ide, Alyssa McNulty, Ellis Gomez, Nicole Donofrio, Tessa Flores, Mary E. Reid
169 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-081: Cancer clinical trial access during the COVID-19 pandemic Ashithkumar Beloor Suresh, Subecha Dahal, Christopher Gantz, AnaMaria Lopez
170 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-027: A Puerto Rico free of preventable diseases: An online education intervention for school staff during the COVID-19 pandemic era in Puerto Rico Diana T. Medina-Laabes, VOCES PR Coalition, JAC-HPV PIVAC PR, Omayra Salgado Cruz, Roxana Soto Abreu, Olga L. Diaz Miranda, et al. (+2)
171 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-065: Increasing breast and cervical cancer knowledge during COVID-19 pandemic in collaboration with Cooperative Extension Program Omayra Salgado, Ircha Martinez, Nelybeth Santiago, Mirza Rivera, Taina De La Torre, Guillermo Tortolero
172 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-093: The impact of the COVID-19 pandemic on care delivery and quality of life in lung cancer surgery Dede K. Teteh, Betty Ferrell, Xiaoke Zou, Loretta Erhunmwunsee, Dan Raz, Jae Kim, Virginia Sun
173 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-238: Implementing a culturally-appropriate biospecimen collection protocol during the COVID-19 pandemic to address cervical cancer disparities among Native American women Skyler Bordeaux, Elisa Martinez, Pawel Laniewski, Natalie Metz, Verity Quioz, Donna Peace, et al. (+3)
174 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-252: Impact of COVID-19 public policies on utilization on cervical cancer screening in Puerto Rico during March 15, 2020 to July 31, 2020 Axel Gierbolini-Bermúdez, Karen Ortiz-Ortiz, Jeslie M Ramos- Cartagena, Kalyani Sonawane, Vivian Colón-Lopez, Ashish Deshmukh, Ana P Ortiz
175 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-250: Impact of age, race, and family history on COVID-19 related changes in breast cancer screening among the Boston Mammography Cohort Study Naiyu Chen, David Cheng, Mollie Barnard, Natalie C. DuPre, Rulla M. Tamimi, Erica T. Warner
176 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-158: Influence of health beliefs on COVID-19 vaccination among patients with cancer and other comorbidities in Puerto Rico McClaren Rodriguez, Andrea López-Cepero, Ana Patricia Ortiz, Emma Fernández-Repollet, Cynthia Pérez
177 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―Jan―11 Abstract PO-029: Community coalition and academic need assessment: Our first step for the development of an educational intervention on HPV vaccination targeting school staff during pandemic era in Puerto Rico Josheili S. Llavona, Diana T. Medina Laabes, Omayra Salgado Cruz, JAC-HPV-PIVac PR, Roxana Soto Abreu, Olga L. Diaz Miranda, et al. (+2)
178 [GO] Cancer Immunology Research 2022―Jan―04 Abstract IA07: Impact of immunotherapy on COVID-19 immunity: Insights from checkpoint blockade in cancer Paulina Coutifaris, Kevin Wang, Sokratis Apostolidis, Mark Painter, Ahron Flowers, Rishi Goel, et al. (+11)
179 [GO] Cancer Immunology Research 2022―Jan―04 Abstract IA08: Adaptive immune dysregulation in cancer patients with SARS-CoV-2 infection Santosha A. Vardhana
180 [GO] Cancer Immunology Research 2022―Jan―04 Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity Mia Han, Jack Y. Lee, Vincent Wu, Kurt Sakurada, Bianca Nguyen, David A. Canton, Christopher G. Twitty
181 [GO] Cancer Discovery 2021―Dec―22 Pandemic Provides Rapid Test of Telehealth
182 [GO] Cancer Discovery 2021―Dec―10 Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, et al. (+13)
183 [GO] Cancer Discovery 2021―Dec―09 Navigating Cancer Care in the COVID-19 Era
184 [GO] Molecular Cancer Therapeutics 2021―Dec―03 Abstract P161: Impaired serological response to SARS-CoV-2 mRNA vaccination in patients with hematologic malignancies Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, Patrick W. Johnson, Louis J. DeGennaro, Gwen L. Nichols
185 [GO] Cancer Research 2021―Nov―10 Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27)
186 [GO] Cancer Discovery 2021―Nov―09 Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, et al. (+5)
187 [GO] Cancer Discovery 2021―Oct―06 COVID-19 Use Causes Tocilizumab Shortage
188 [GO] Cancer Prevention Research 2021―Oct―04 Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies Ana Ribeiro, Flávia Corrêa, Arn Migowski, Aline Leal, Sandro Martins, Tainá Raiol, et al. (+8)
189 [GO] Clinical Cancer Research 2021―Sep―28 Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, et al. (+18)
190 [GO] Blood Cancer Discovery 2021―Sep―15 How to provide the needed protection from COVID-19 to patients with hematologic malignancies Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D. Gore, Ronald Levy, Lee M Greenberger
191 [GO] Blood Cancer Discovery 2021―Sep―13 Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies David J Chung, Gunjan L. Shah, Sean M. Devlin, Lakshmi V Ramanathan, Sital Doddi, Melissa S Pessin, et al. (+18)
192 [GO] Blood Cancer Discovery 2021―Sep―13 Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy Roni Tamari, Ioannis Politikos, David A Knorr, Santosha A Vardhana, Jennifer C Young, LeeAnn T Marcello, et al. (+12)
193 [GO] Cancer Discovery 2021―Sep―01 Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? Bérengère Salomé, Amir Horowitz
194 [GO] Cancer Discovery 2021―Jul―21 Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret
195 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―16 Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernandez-Bertolin, Maria Aragon, et al. (+47)
196 [GO] Cancer Discovery 2021―Jul―16 Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine
197 [GO] Cancer Discovery 2021―Jul―07 COVID-19 Vaccines Complicate Breast Screening
198 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―07 Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet Van Eycken
199 [GO] Cancer Research 2021―Jul―01 Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6)
200 [GO] Cancer Research 2021―Jul―01 Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9)
201 [GO] Cancer Research 2021―Jul―01 Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3)
202 [GO] Cancer Research 2021―Jul―01 Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki
203 [GO] Cancer Research 2021―Jul―01 Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan
204 [GO] Cancer Research 2021―Jul―01 Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2)
205 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 74: Stakeholder Selected Strategies to Improve Breast Cancer Care in East Africa: Preliminary Implementation Outcomes and Impact Of COVID-19 Anne Rositch, Christina Chao, Matogoro Kirahi, Nestory Masalu, Lucas Faustine, Leonard Washington Amango
206 [GO] Cancer Research 2021―Jul―01 Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig
207 [GO] Cancer Research 2021―Jul―01 Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6)
208 [GO] Cancer Research 2021―Jul―01 Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4)
209 [GO] Cancer Research 2021―Jul―01 Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2)
210 [GO] Cancer Research 2021―Jul―01 Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17)
211 [GO] Cancer Research 2021―Jul―01 Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3)
212 [GO] Cancer Research 2021―Jul―01 Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom
213 [GO] Cancer Research 2021―Jul―01 Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6)
214 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 11: Neglected Elements of Cancer Control During The COVID-19 Pandemic in Africa: Call for Action from 2019-2020 African Cancer Research and Control ECHO Programme Annet Nakaganda, Nwamaka Lasebikan, Elise M. Garton, Benda Kithaka, Mishka K. Cira
215 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 31: Impact of the COVID-19 Pandemic on Cancer Registry Operations in the Caribbean Sarah Quesnel-Crooks, Rachel Hanisch, Isabelle Soerjomataram, Brenda Edwards, Arica White, Betsy Kohler, et al. (+3)
216 [GO] Cancer Research 2021―Jul―01 Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain
217 [GO] Cancer Research 2021―Jul―01 Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5)
218 [GO] Cancer Research 2021―Jul―01 Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs Said A. Goueli, Kevin Hsiao
219 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 65: Early Assessment of the Pandemic Effects on Cancer Screening Services: The International Cancer Screening Network COVID-19 Survey Douglas M. Puricelli Perin, K. Miriam Elfström, Mireille J. M. Broeders
220 [GO] Cancer Research 2021―Jul―01 Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
221 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 18: Cancer Control Assessments in Low- and Middle-Income Countries during COVID-19: The IAEA-IARC-WHO imPACT Review Hybrid Modality Marianna Nobile, Kendall Siewert, Maria Tena Perpina, Yuliya Lyamzina
222 [GO] Cancer Research 2021―Jul―01 Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi
223 [GO] Cancer Research 2021―Jul―01 Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle
224 [GO] Cancer Research 2021―Jul―01 Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra
225 [GO] Cancer Research 2021―Jul―01 Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu
226 [GO] Cancer Research 2021―Jul―01 Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
227 [GO] Cancer Research 2021―Jul―01 Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell
228 [GO] Cancer Research 2021―Jul―01 Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3)
229 [GO] Cancer Research 2021―Jul―01 Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post
230 [GO] Cancer Research 2021―Jul―01 Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25)
231 [GO] Clinical Cancer Research 2021―Jun―09 A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes David A. Potter, Alexandra Thomas, Hope S. Rugo
232 [GO] Cancer Discovery 2021―Jun―04 COVID-19 Reshapes Cancer Clinical Research
233 [GO] Cancer Discovery 2021―May―19 Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16)
234 [GO] Cancer Discovery 2021―May―14 Blood Cancers Diminish Response to COVID-19 Vaccine
235 [GO] Cancer Prevention Research 2021―Apr―28 Q&A: Ned Sharpless on COVID-19 and Cancer Prevention
236 [GO] Cancer Discovery 2021―Apr―12 Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria
237 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Voices of Community Organizations: How Cancer Centers Can Support Communities in the Face of COVID-19 JD Austin, E Lee, RC Shelton, G Hillyer, K Schmitt, P Tehranifar
238 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors TA Hastert, JJ Ruterbusch, AL Best, FWK Harper, H Thompson, JL Beebe-Dimmer, AG Schwartz
239 [GO] Cancer Discovery 2021―Apr―02 Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic Chris Labaki, Solange Peters, Toni K. Choueiri
240 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI) AR Peoples, C Himbert, CA Hathaway, AC Kirchhoff, J Ose, T Lin, et al. (+9)
241 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Improving Survey Response Rates Among Patients at a Cancer Center During a Global Pandemic CA Hathaway, EM Siegel, B Gonzalez, SS Tworoger
242 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay
243 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha
244 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 Giulia Monticone, Alistair Ramsay, Lucio Miele
245 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, et al. (+3)
246 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler
247 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew
248 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay
249 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19)
250 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly
251 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+24)
252 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, et al. (+2)
253 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh
254 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, et al. (+9)
255 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, et al. (+3)
256 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, et al. (+35)
257 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, et al. (+16)
258 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses Richard Momparler
259 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare
260 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, et al. (+2)
261 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard
262 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi
263 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, et al. (+20)
264 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, et al. (+14)
265 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom Menna M. Fouda, Ankit Jain
266 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection Jian He, Mei Meng, Yiyang Zhao
267 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, et al. (+14)
268 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, et al. (+9)
269 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita
270 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh
271 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, et al. (+22)
272 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, et al. (+9)
273 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni
274 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, et al. (+5)
275 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot
276 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic Md Mohiuddin, Kazuo Kasahara
277 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, et al. (+2)
278 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis
279 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, et al. (+5)
280 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion Mary N. O'Reilly, Mark Doherty
281 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, et al. (+6)
282 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, et al. (+4)
283 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, et al. (+12)
284 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, et al. (+4)
285 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji
286 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, et al. (+22)
287 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3)
288 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera
289 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan
290 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, et al. (+8)
291 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, et al. (+15)
292 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, et al. (+2)
293 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler
294 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, et al. (+5)
295 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, et al. (+15)
296 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park
297 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures Arutha Kulasinghe
298 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, et al. (+4)
299 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, et al. (+9)
300 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, et al. (+25)
301 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
302 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, et al. (+6)
303 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, et al. (+6)
304 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, et al. (+8)
305 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo
306 [GO] Clinical Cancer Research 2021―Mar―01 Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain
307 [GO] Cancer Discovery 2021―Feb―26 COVID-19 Prolonged in Patients with Cancer
308 [GO] Cancer Prevention Research 2021―Feb―24 COVID-19 disruptions to endoscopic surveillance in Lynch syndrome Danielle B McKenna, Christina M Dudzik, Shria Kumar, Nadim Mahmud, Bryson W Katona
309 [GO] Cancer Research 2021―Feb―15 Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study Ali Raza Khaki, Dimpy P Shah, Maryam B Lustberg, Melissa K Accordino, Daniel G Stover, Gayathri Nagaraj, et al. (+15)
310 [GO] Cancer Research 2021―Feb―15 Abstract PS12-26: “Bridge” neoadjuvant endocrine therapy for early stage breast cancer patients during COVID-19 at an academic hospital in NYC: Lessons learned Cindy Cen, Freya Schnabel, Sylvia Adams, Magdalena Plasilova, Janet Yeh, Marleen Meyers, et al. (+6)
311 [GO] Cancer Research 2021―Feb―15 Abstract PS8-26: The new normal; adjusting to remote ways of providing bespoke weight management support to breast cancer survivors during the COVID-19 global pandemic Katie Pickering, Sarah Wane, Helen Speake, Helen Crank, Annie Anderson, Henry Cain, et al. (+9)
312 [GO] Cancer Research 2021―Feb―15 Abstract SS2-03: Patterns of medical behavior in the management of breast cancer during COVID-19. Mexican Experienc Ricardo Villalobos Valencia, Samuel Rivera Rivera
313 [GO] Cancer Research 2021―Feb―15 Abstract PS6-32: Impact of COVID-19 on breast cancer care at a Bay Area academic center Julie Wu, Sally Bobo, Solomon Henry, Meredith Mills, Allison Kurian, Frederick Dirbas
314 [GO] Cancer Research 2021―Feb―15 Abstract SS2-10: Impact of COVID-19 on study sites: Survey analysis from the noninterventional POLARIS study Debu Tripathy, Joanne L Blum, Gabrielle Rocque, J. Daniel Cuevas, Jennifer Specht, Steven Corso, et al. (+5)
315 [GO] Cancer Research 2021―Feb―15 Abstract SS2-04: Health maintenance and breast cancer screening during the COVID-19 pandemic Arash Naeim, Neil Wenger, Karen Sepucha, Annette Stanton, Ryan Baxter-King, Leah Sabacan, et al. (+5)
316 [GO] Cancer Research 2021―Feb―15 Abstract SS2-09: Telemedicine usability for cancer care during the COVID-19 pandemic Andrea Leon, Rebecca Kaltman, Hannah Arem, Richard Amdur, Andrea Gesteira, Samuel Duffy, et al. (+3)
317 [GO] Cancer Research 2021―Feb―15 Abstract PS2-27: Benefits of a rapid diagnostic centre for breast cancer care during the COVID-19 pandemic Gary Ko, Sharmy Sarvanantham, Sangita Sequeira, Vrutika Prajapati, David R. McCready, Vivianne Freitas, Tulin D. Cil
318 [GO] Cancer Research 2021―Feb―15 Abstract PS13-30: Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic Franklin F Pimentel, Jessica MC Borba, Tamara CGF Rodrigues, Karoline PI Peruchi, Helio HA Carrara, Jurandyr M de Andrade, Francisco J Candido dos Reis
319 [GO] Cancer Research 2021―Feb―15 Abstract SS2-02: Patient perception of breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, et al. (+4)
320 [GO] Cancer Research 2021―Feb―15 Abstract SS2-08: Patient perception of telehealth services for breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, et al. (+4)
321 [GO] Cancer Research 2021―Feb―15 Abstract PS11-21: First-line treatment trends in metastatic breast cancer before and at the early stage of the COVID-19 pandemic in the United States Samantha Kurosky, Xianchen Liu, Aster Meche, Rebecca Levin, Amy Sullivan, Lynn McRoy
322 [GO] Cancer Research 2021―Feb―15 Abstract PS7-88: Effect of the COVID-19 pandemic on the initial treatment of breast cancer in the Netherlands: A population-based study Anouk H Eijkelboom, Linda de Munck, Marie-Jeanne Vrancken Peeters, Marjolein Smidt, Mireille Broeders, Monique Bos, et al. (+14)
323 [GO] Cancer Research 2021―Feb―15 Abstract SS2-01: Impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: Initial analysis of the american society of breast surgeons mastery COVID-19 registry Lee Gravatt Wilke, Toan T Nguyen, Qiuyu Yang, Bret M Hanlon, Kathryn A Wagner, Pamela Strickland, et al. (+3)
324 [GO] Cancer Research 2021―Feb―15 Abstract SS2-07: Predictors for fear of cancer recurrence in breast cancer patients referred for radiation therapy during the COVID-19 pandemic: A multi-center cross-section survey Jinrong Xie, Weixiang Qi, Lu Cao, Yuting Tan, Jin Huang, Xiaodong Gu, et al. (+20)
325 [GO] Cancer Research 2021―Feb―15 Abstract SS2-05: Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer Ko Un Park, Megan E Gregory, Maryam B Lustberg, Jose G Bazan, Chengli Shen, Shoshana M Rosenberg, et al. (+5)
326 [GO] Cancer Research 2021―Feb―15 Abstract PS6-47: Breast cancer and COVID-19: Impact of active treatment on severe outcomes Karine Tawagi, Jeff Burton, Michael Lunski, Diana Maslov, John Cole
327 [GO] Cancer Research 2021―Feb―15 Abstract PS2-32: Incidental malignant findings on pre-admission chest computed tomography scan for coronavirus disease screening in patients with breast cancer or other cancers Jun Masuda, Akemi Kataoka, Katsunori Oikado, Natsue Uehiro, Yukinori Ozaki, Lina Inagaki, et al. (+5)
328 [GO] Cancer Research 2021―Feb―15 Abstract SS2-06: Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment Sharon B. Chang, Alison C. Savitz, Brooke Vuong, Annie Tang, Margaret Mentakis, Amy M. Miller, et al. (+2)
329 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Feb―05 Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? Anita W.W. Lim
330 [GO] Clinical Cancer Research 2021―Feb―04 How did we get a COVID-19 vaccine in less than one year? E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas
331 [GO] Cancer Discovery 2021―Feb―02 Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
332 [GO] Cancer Immunology Research 2021―Jan―15 At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer Antoni Ribas, Marina Chiara Garassino
333 [GO] Blood Cancer Discovery 2021―Jan―13 Cancer and COVID-19: On the Quest for Effective Vaccines Marwan Kwok, Edward F. Fritsch, Catherine J. Wu
334 [GO] Cancer Discovery 2020―Dec―30 Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
335 [GO] Cancer Research 2020―Dec―22 Is COVID-19 - induced platelet activation a cause of concern for cancer patients? Lenard M. Lichtenberger, K. Vinod Vijayan
336 [GO] Cancer Discovery 2020―Dec―22 Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4)
337 [GO] Cancer Discovery 2020―Dec―22 As Pandemic Continues, Screening Concerns Grow
338 [GO] Molecular Cancer Research 2020―Dec―16 Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy Miran Rada, Zahraa Qusairy, Marta Massip-Salcedo, Salvador Macip
339 [GO] Cancer Discovery 2020―Dec―11 Survival Factors ID'd for Patients with Blood Cancer + COVID-19
340 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-040: Florida-California CaRE2 Health Equity Center Citizen Scientist Training Program: Going virtual in response to COVID-19 Nissa Askins, Fern J. Webb, Linda Behar-Horenstein, Lourdes Baezconde-Garbanati, Sandra Suther, Diana J. Wilkie, Folakemi T. Odedina
341 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract IA10: The Prevent Anal Cancer Study: the assessment of novel opportunities for anal cancer screening during COVID-19 Alan G. Nyitray
342 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S01-01: Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19 Qu Deng, Reyaz Ur Rasool, Ramakrishnan Natesan, Irfan A. Asangani
343 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-069: SRMS correlated with immune infiltration and lung cancer: Allusion for COVID-19 Beesetti Swarna, Yong-Dong Wang, Malia B. Potts
344 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-032: Patient-centered communication: Collaborative learning and communication strategies for patients and health care providers in the new normal of COVID-19 Martha Raymond, Margaret-Ann Simonetta
345 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-011: CiRCL: A psychosocial program facilitating communication and care to patients, families, and frontline health care teams during COVID-19 Kauser Ahmed, Peter Phung, Noah Goldstein, John Glaspy
346 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-012: Clinical features and antibody response of two pediatric patients presenting with new-onset acute myeloid leukemia and concomitant severe COVID-19 Pratik A. Patel, Christina A. Rostad, Stacey A. Lapp, Claire L. Stokes, Melinda G. Pauly, Evan J. Anderson, Himalee S. Sabnis
347 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S10-02: Using real-world data (RWD) from an integrated platform for rapid analysis of patients with cancer with and without COVID-19 across distinct health systems Shirish M. Gadgeel, Michael A. Thompson, Monika A. Izano, Clara Hwang, Tom Mikkelsen, James L. Weese, et al. (+7)
348 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-272: COVID-19 adaptations to patient navigation services for follow-up colonoscopy after an abnormal fecal test result in a community health center setting Jamie Thompson, Jennifer Rivelli, Amanda Petrik, Jennifer Schneider, Neha Yadav, Hanna Dinh, et al. (+5)
349 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S06-01: Changes implemented by U.S. oncology practices in response to COVID-19 pandemic: Initial report from the ASCO Registry on COVID-19 and cancer Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Stephen Meersman, Patricia Hurley, Brian Bourbeau, Allyn Moushey, et al. (+4)
350 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA26: Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums Brian I. Rini
351 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-061: Data harmonization for COVID-19 and cancer research registries Rimma Belenkaya, Adam Watson, Shantha Bethusamy, Meera Patel, Tatyana Sandler, Julian Schwartz, et al. (+6)
352 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-263: COVID-19 and social determinants of health (SDOH): Impact on cancer prevention in vulnerable populations Beth A. Jones, Sakinah Suttiratana, Roy Herbst, William Eger, Eiman Ibrahim, Hannah Behringer, et al. (+8)
353 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study Annika Fendler, Laurie Boos, Lewis Au, Scott Shepherd, Fiona Byrne, Kim Edmonds, et al. (+7)
354 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-121: COVID-19, cancer, and racial health disparities Linda S. Behar-Horenstein, Keesha Powell-Roach, Staja Q. Booker, Michael U. Maduka, Destiny Gordon, Kayanna Jacobs, Debra Lyon
355 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-019: Impact of a hospital conversion to COVID-19 center on cancer care of patients in a urologic oncology clinic in Mexico Salvador G. Santiesteban, Haydee Verduzco-Aguirre, Christianne Bourlon, Maria T. Bourlon
356 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S12-03: Thoracic cancers international COVID-19 collaboration (TERAVOLT): Small-cell lung cancer and other rare thoracic malignancies Alessio Cortellini, Anne-Marie C. Dingemans, Oscar Arrieta, Javier Baena, Matteo Brighenti, Enriqueta Felip, et al. (+19)
357 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-004: Association between county-level socioeconomic characteristics and health indicators with COVID-19 deaths in Florida Gebre-Egziabher Kiros, Kira Gaddis
358 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA20: Potential insights into COVID-19 disparities from the science of cancer health disparities John M. Carethers
359 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S09-04: Unemployment and cancer screening: Baseline estimates to inform health care provision in the context of COVID-19 economic distress Stacey A. Fedewa, K. Robin Yabroff, Zhiyuan Zheng, Priti Bandi, Ann Goding Sauer, Robert A. Smith, et al. (+3)
360 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-005: Barriers to implementation of virtual collection of patient-reported data in the COVID-19 era Karineh Kazazian, Wendy Johnston, Jessica Bogach, Carol J. Swallow
361 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-042: Would dermoscopic photographs help triage teledermatology consults in the COVID-19 era? Myles R. McCrary, Tova Rogers, Howa Yeung, Loren Krueger, Suephy C. Chen
362 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness Antonio Calles, Mar Galera, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, et al. (+3)
363 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-027: Multi-institutional survey of COVID-19 impact in cancer care in patients and health care providers Sylvia V. Alarcon, Omid Salehi, Eduardo A. Vega, Vera Kazakova, Claudius Conrad
364 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S07-01: Examining COVID-19 preventive behaviors among cancer survivors in the United States: An analysis of the COVID-19 Impact Survey Jessica Y. Islam, Marlene Camacho-Rivera, Denise C. Vidot
365 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-062: Early impact of COVID-19 in cancer care: The experience of a Brazilian outpatient clinic Cinthya Sternberg, Bianca Vivas, Thamine Lessa Andrade, Ana Paula Vila Nova, Ana Paula Fernandes, Camila Alves, et al. (+7)
366 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI) Aljosja Rogiers, Carlo Tondini, Joe M. Grimes, Megan H. Trager, Sharon Nahm, Leyre Zubiri, et al. (+19)
367 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients Antonio Calles, Manuel Alva, Inmaculada Aparicio, Javier Soto, Natalia Gutierrez, Marianela Bringas, et al. (+4)
368 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-060: COVID-CANCER HUIL STUDY: Registry of oncologic patients diagnosed with Covid-19 in Infanta Leonor University Hospital in Madrid, Spain Jacobo Rogado, Berta Obispo, Gloria Serrano-Montero, Almudena Martin Merino, Ana Lopez-Alfonso, Cristina Pangua, et al. (+3)
369 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-059: COVID-19 in melanoma patients: Spanish register Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodriguez-Jiménez, Mónica Antoñanzas Basa, Marta Feito Rodríguez, et al. (+19)
370 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S04-01: Famotidine use and quantitative symptom tracking for COVID-19 in nonhospitalized patients: A case series Tobias Janowitz, Eva C. Gablenz, David J. Pattinson, Timothy C. Wang, Joseph Conigliaro, Kevin J. Tracey, David A. Tuveson
371 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-028: One piece of the jigsaw for the cancer recovery strategy: Prevalence of COVID-19 in patients with cancer Charlotte Moss, Beth Russell, Mary Lei, Sharmista Ghosh, Sophie Papa, Richard Sullivan, et al. (+2)
372 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid Antonio Calles, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, et al. (+2)
373 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA04: COVID-19 in patients with lung cancers in New York City Jia Luo, Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chaitanya Bandlamudi, et al. (+6)
374 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-035: Public social media discussion of COVID-19 in relation to cancer services disruption Damian Eade, Laura Galimam, Mónica Fernández-Sierra, Caryn Gordon, Jason McDonough
375 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-079: COVID-19 in relation to hematologic events and mortality in subset of inpatient cancer patients Saikrishna Gadde, Ambuga Badari, John Cole, Nikhil Manjunath
376 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-086: Covid-19 in the city of Teofilo Otoni-Minas Gerais: Current panorama and future perspectives Laryssa Reis Coelho, Gustavo da Mata Oliveira Rezende, Virgílio Barroso de Aguiar, Vânia Soares Oliveira e Almeida Pinto, Rafael Genaro, Rafael Alvarenga Almeida, et al. (+7)
377 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S09-01: Cancer and race: Two important risk factors for COVID-19 incidence as captured by the COVID Symptom Study real-time epidemiology tool David A. Drew, Long H. Nguyen, Wenjie Ma, Chun-Han Lo, Amit D. Joshi, Daniel Sikavi, et al. (+6)
378 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic Pablo Tolosa, Ana Sanchez-Torre, Helena Bote de Cabo, Rodrigo Sánchez-Bayona, Mercedes Herrera, Ramón Yarza, et al. (+3)
379 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-081: Outcomes of patients with multiple myeloma with COVID-19 infection Michael John Lunski, Karine Tawagi, Diana Maslov, Laura Finn
380 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-067: Tissue banking from patients with SARS-CoV-2 (COVID-19) infection Emily F. Higgs, Blake A. Flood, Athalia R. Pyzer, Sherin J. Rouhani, Jonathan A. Trujillo, Kyle R. Cron, et al. (+8)
381 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-025: Management of breast cancer surgery during de-escalation of COVID-19 infection Juana María Brenes Sánchez, Amanda López Picado, María Eugenia Olivares Crespo, José Ángel García Sáenz, Rosa María De La Plata Merlo, María Herrera De La Muela
382 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S12-01: High mortality among hospital-acquired COVID-19 infection in patients with cancer: An observational cohort study from Q and British Columbia Arielle Elkrief, Antoine Desilets, Neha Papneja, Lena Cvetkovic, Catherine Groleau, Yahia Abdelali Lakehal, et al. (+18)
383 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-078: Clinical characteristics and outcomes of cancer patients with COVID-19 infection: A retrospective study in a single center in the Philippines Jessa Gilda P. Pandy, Michelle Joane Alcantara, Frances Victoria Que, Marie Belle Francia
384 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-071: Collaborating to share evidence-based COVID-19 information across lung cancer patient advocacy groups Amy C. Moore, Janet Freeman-Daily, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Upal Basu Roy
385 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-051: Intracellular delivery of nuclear localization signal suppresses COVID-19 mediated inflammation by regulating expression of cytokines/chemokines Danbi Lee, Sanghyeon Yu, Misuk Baek, Jieun Kim, Mingu Kang, Hakyoung Park, et al. (+14)
386 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-070: What kills patients with severe Covid-19 might also kill patients with terminal cancer Lingbing Zhang
387 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S11-03: Impact of COVID-19 on breast and prostate cancer screening and early detection in a large health care provider group Mara M. Epstein, Devi Sundaresan, Meagan Fair, Lawrence Garber, Mary Charpentier, Jerry H. Gurwitz, Terry S. Field
388 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study Sharlene Gill, Bruce Colwell, Hal Hirte, Welch Stephen, Alexi Campbell, Desiree Hao
389 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-077: Impact of COVID-19 on patient navigation for cancer treatment Sanja Percac-Lima, Erica T. Warner, Emma C. Whited, Kelly E. Irwin, Aileen Navarrete, Carmen Benjamin, et al. (+6)
390 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-089: The impact of Covid-19 on public generosity toward cancer-related crowdfunding efforts Katrina A. Fischer, Robert E. Miller, Sidharth Anand, John Glaspy
391 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S07-02: Patient-reported outcomes of breast cancer patients during the COVID-19 outbreak in the epicenter of China: A cross-sectional survey study Juanjuan Li, Cesar Augusto Santa-Maria, Hongfang Feng, Lingcheng Wang, Pengcheng Zhang, Yuangbing Xu, et al. (+10)
392 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-007: Breast cancer management during COVID-19 outbreak: Learned lessons Juana María Brenes Sánchez, Amanda López Picado, José Ángel García Sáenz, María Eugenia Olivares Crespo, Rosa María De La Plata Merlo, María Herrera De La Muela
393 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London Beth Russell, Charlotte Moss, Sophie Papa, Sheeba Irshad, Paul Ross, James Spicer, et al. (+18)
394 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-101: Patient experiences and opinions using teleoncology in a safety-net hospital during the COVID-19 pandemic Andrew Wiele, Tejal A. Patel, Sarah Rizvi, Patricia De Los Rios, Kristyn-Mae Russo, Demetria Smith, et al. (+3)
395 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-075: Barriers and facilitators to recruiting research study participants from community-based HIV/AIDS service organizations: Lessons learned during the COVID-19 pandemic Lisa T. Wigfall
396 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-037: Challenges and solutions in outreach activities encountered in dealing with Micronesians amid the COVID-19 pandemic Srue H. Wakuk
397 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-056: Using MammaPrint to reduce the need for chemotherapy in early breast cancer during the COVID-19 pandemic Elizabeth M. Murray, Ettienne J. Myburgh, Ersan Lujinovic, Lorenza Mittempergher, Duncan J. Robertson, Josephus J. de Jager, Maritha J. Kotze
398 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic Heather A. Lankes, Mark A. Watson, Richard C. Jordan, Nilsa C. Ramirez, Ignacio I. Wistuba, Lois Shepherd, et al. (+2)
399 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-009: Cancer-related distress among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Jenny Ahlstrom
400 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA16: COVID-19 pandemic and its effect on the psychological status of cancer patients and oncologists Gabriella Pravettoni
401 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-087: COVID-19 pandemic in Italy: Social distress and gender imbalance among health care professionals Rossana Berardi, Mariangela Torniai, Maria Silvia Cona, Fabiana Cecere, Rita Chiari, Valentina Guarneri, et al. (+5)
402 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-008: Cancer care during the COVID-19 pandemic in Southern India Anita Ramesh, Raji Ssoundarajan
403 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S11-02: Patient-reported impact of the COVID-19 pandemic on breast cancer screening, diagnosis, and treatment: A national survey Erica T. Warner, Emily Restrepo, Christine Benjamin, Ricki Fairley, Laura Roudebush, Leah Eshraghi, et al. (+3)
404 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-040: The Effects of the COVID-19 pandemic on cancer patient encounters Jack W. London, Elnara Fazio-Eynullayeva, Matvey Palchuk, Corinna Mossop, Peter Sankey, Christopher McNair
405 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-041: The impact of the COVID-19 pandemic on cancer patients Lola Rahib, Zach Kaufman, Erika Vial Monteverdi
406 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S11-01: Assessing the impact of the COVID-19 pandemic on cancer patients, survivors, and caregivers Amy Leader, Preethi Selvan, Lisa Capparella, Rebecca Cammy, Janene Palidora, Ayako Shimada, et al. (+3)
407 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-033: Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey Marc Hilmi, Alice Boilève, Anabelle Ducousso, Morgan Michalet, Anthony Turpin, Cindy Neuzillet, Natacha Naoun
408 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-023: Impact of the Covid-19 pandemic on medical oncology utilization at a busy urban academic medical center Sidharth Anand, Anne Walling, Neil Wenger, Katrina Fischer, Lisset Huerta-Cruz, Lisa Wilen, John Glaspy
409 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network Brian Bourbeau, Mou Guharoy, Elizabeth Garrett-Mayer, Stephen Grubbs, Paul Unger, Barbara McAneny, Richard L. Schilsky
410 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-073: Effect of the COVID-19 pandemic on oncologists’ online CME consumption and educational needs Michelle A. Worst, Katie Lucero
411 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-017: Evaluating the impact of the coronavirus (COVID-19) pandemic on treatment paradigms in head and neck cancer at a tertiary care hospital Joshua A. Thompson, Reju Joy, Joshua E. Lubek, Ranee Mehra, Jason K. Molitoris, Rodney J. Taylor, et al. (+3)
412 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-088: COVID-19 pandemic slows launch of oncology clinical trials Elizabeth B. Lamont, Sheila S. Diamond, Ron G. Katriel, Jingshu Lui, Lisa Ensign, Caleb Alexander
413 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-003: Early detection of breast cancer during the Covid-19 pandemic using artificial intelligence neural networks Subash Kumar
414 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-038: Strong decline of newly diagnosed gynecologic and breast cancers during the COVID-19 pandemic: A retrospective analysis from Innsbruck, Austria Irina Tsibulak, Elisabeth Reiser, Christoph Ebner, Katharina Knoll, Katharina Leitner, Verena Wieser, et al. (+2)
415 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-080: Increasing of emergency presentation on colorectal cancer patients during COVID-19 pandemic: A retrospective study on single-center academic hospital Budhi Ida Bagus, Metria Ida Bagus, Setyawati Ida Ayu, Mastini Ida Ayu Kade
416 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-074: Patient concerns during the COVID-19 pandemic: Lessons from the lung cancer community Janet Freeman-Daily, Upal Basu Roy, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Amy C. Moore
417 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-037: SKCC medical oncology telehealth experience during Covid-19 pandemic: Lessons learned and operational changes to leverage telehealth to maintain patient access Avnish Bhatia, Lauren Waldman, Gregory Garber, Megan Sabonjian, Melissa Hunt, Janene Palidora, et al. (+2)
418 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-052: COVID-19 pandemic: Patients’ perspective during cancer treatment Filippo Merloni, Nicoletta Ranallo, Lucia Bastianelli, Francesca Vitarelli, Luca Cantini, Zelmira Ballatore, et al. (+13)
419 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-076: Training and information during COVID-19 pandemic: The masterpiece in young oncologists Nicoletta Ranallo, Lucia Bastianelli, Filippo Merloni, Luca Cantini, Giulia Ricci, Zelmira Ballatore, Rossana Berardi
420 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-034: Prospective planning of radiation treatment at new patient conference during the COVID-19 Pandemic: The University of Mississippi Medical Center experience Sanjay Joseph, Mary Nittala, Paul Roberts, Maurice King, Hiba Ahmed, Ashley Albert, et al. (+5)
421 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S05-01: Profound CD8 T-cell responses towards SARS-CoV-2 OFR1ab in COVID-19 patients Anastasia Gangaev, Steven L. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, et al. (+13)
422 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-068: Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients Ugo Rovigatti, Amedeo Vannacci, Simone Del Corto, Ignacio Martin-Loeches, Andrea Piccin, Nizar Naji, Carmel Mothersill
423 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-050: Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer Giulia Russo, Luca Falzone, Bruno Cacopardo, Giuseppe Nunnari, Francesco Torino, Giuseppa Scandurra, et al. (+3)
424 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S12-02: Risk of morbidity and mortality in COVID-19 patients with cancer Naomi Alpert, Bridget Marcellino, Joseph Rapp, Wil Lieberman-Cribbin, Emanuela Taioli
425 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-063: Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis Isaac Klein, Shoshana Rosenberg, Camille Kotton, Kerry Reynolds, Leyre Zubiri, Rachel Gaither, et al. (+8)
426 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-093: Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day-7 interim analysis of a registered clinical trial Clayton B. Hess, Zachary S. Buchwald, William Stokes, Tahseen H. Nasti, Jeffrey M. Switchenko, Brent D. Weinberg, et al. (+6)
427 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S05-02: COVIDOSE: Low-dose tocilizumab in the treatment of COVID-19 pneumonitis Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani, Jonathan A. Trujillo, Athalia R. Pyzer, Jovian Yu, et al. (+17)
428 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-057: Cancer center support for understanding statewide COVID-19 prevalence and early detection Jackilen Shannon, David Bangsberg, Paul Spellman, Bridget Barnes, Jenny Lee Berry, Kim Brown, et al. (+6)
429 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA13: Treatment of COVID-19 pulmonary failure by targeting BTK Steven Peter Treon
430 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S10-01: COVID-19 severity and outcomes in hospitalized patients with cancer at a New York City tertiary medical center: A matched cohort study Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman, Brandon Swed, Evgeniya Reshentnyak, Orysya Soroka, et al. (+7)
431 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-029: Operationalizing a prioritized COVID-19 testing strategy at a Canadian tertiary care cancer center April A. Hildebrand, Desiree Hao, Safiya Karim, Winson Y. Cheung, Don Morris, Daniel Y. C. Heng
432 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S02-02: Covid-19 treatment candidate hydroxychloroquine impairs tumor response to anti-PD1 Simon Wabitsch, Jack C McVey, Chi Ma, Benjamin Ruf, Laurence Diggs, Bernd Heinrich, Tim F Greten
433 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S01-02: Optimizing treatment for COVID-19 using computational modeling: Implications for cancer patients Chrysovalantis Voutouri, Mohammadreza Nikmaneshi, Melin Khandekar, Ankit B. Patel, Ashish Verma, Sayon Dutta, et al. (+3)
434 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-046: Assessment of COVID-19 vaccine candidates: Prediction and validation of 174 SARS-CoV-2 epitopes Marek Prachar, Sune Justesen, Daniel Bisgaard Steen-Jensen, Stephan Thorgrimsen, Erik Jurgons, Ole Winther, Frederik Otzen Bagger
435 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-026: Minimize impact of pandemic on radiation oncology department: Experience from a moderate-sized regional cancer program in the battle against COVID-19 virus Ming Pan, Khalid Hirmiz, Junaid Yousuf, Kitty Huang, Colvin Springer, Ken Schneider, Laura D’Alimonte
436 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA09: A phase II trial to promote recovery from COVID-19 with endocrine therapy Catherine H. Marshall, Srinivasan Yegnasubramanian, Hao Wang, Jennifer Durham, Ting Wang, Rachel Damico, et al. (+8)
437 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-002: RUXCOVID: A phase 3, randomized, placebo-controlled study evaluating the efficacy and safety of ruxolitinib in patients with COVID-19-associated cytokine storm MeiLan K. Han, Rachel Ann Bender Ignacio, Amparo Lopez Bernus, Katrin Milger-Kneidinger, Amesika N. Nyaku, Ben Parker, et al. (+6)
438 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-085: Sex bias in COVID-19-associated Illness severity and mortality in cancer patients: A systematic review and meta-analysis Robin Park, Anusha Chidharla, Kathan Mehta, Weijing Sun, Anup Kasi
439 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S10-03: Increased risk of COVID-19-related death among cancer survivors Jie Shen, Hua Zhao
440 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-082: Preliminary analysis of factors associated with COVID-19-related disease severity in cancer patients: University of Kansas Cancer Center experience Anup Kasi, Elizabeth Wulf-Burchfield, Natalie Streeter, Stephen Jackson, David Streeter, Eric Crowder, et al. (+2)
441 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S07-04: Impact of COVID-19-related psychosocial distress on health-related quality of life in rural cancer survivors Scherezade K. Mama, Michelle Cardel, Kathryn H. Schmitz
442 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-083: Prostate cancer and COVID-19: Impact of hormonal therapy on severe outcomes Karine Tawagi, Jeff Burton, Diana Maslov, Michael Lunski, Marc Matrana, Daniel Johnson
443 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-045: Multiplex analysis of coronavirus and influenza antibodies using the ZIVA multiplex platform Jon Schmuke, Ben Miller, Linda Meeh, Byran Witherbee
444 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S06-03: Cancer care telehealth utilization rates and provider attitudes in the wake of the novel coronavirus pandemic: The Kaiser Permanente Northern California experience Elad Neeman, Tatjana Kolevska, Mary Reed, Tilak Sundaresan, Amit Arora, Yan Li, et al. (+6)
445 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S03-01: Pan-HLA prediction of SARS-CoV-2 epitopes Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi
446 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-004: A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer-directed therapy Winston Wong, Claire Brevia, Michael May, Susan Whittier, Eldad Hod, Ilenia Pellicciotta, et al. (+3)
447 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S02-03: SARS-CoV-2 induces inflammatory cytokine release, which may be exacerbated by immune checkpoint blockade Layne Weatherford, Maria Lehn, McKenzie Crist, Chelsea Wendling, Kristin Hudock, Vinita Takiar, Trisha Wise-Draper
448 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S09-02: Outcomes by race for cancer patients hospitalized with SARS-CoV-2 infection Steven S. Chang, Clara Hwang, Mohamed A. Elshaikh, Amy Tang, Christine M. Neslund-Dudas, Albert M. Levin, et al. (+2)
449 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection Alexandra Cabanov, Blake A. Flood, Jeffrey Bloodworth, Emily F. Higgs, Jessica Fessler, Michael Y.K. Leung, et al. (+12)
450 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S01-03: A prediction of prostate cancer deaths spiking by SARS-CoV-2 infection Alakesh Bera, Eric Russ, Digonto Chatterjee, John Karaian, Madhan Subramanian, Sreejato Chatterjee, et al. (+4)
451 [GO] Clinical Cancer Research 2020―Dec―03 Abstract IA03: Systems approaches reveal shared pathways affected in SARS-CoV-2 infection and cancer Nevan Krogan
452 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-024: Incidence of SARS-COV-2 infection in cancer patients undergoing active treatment Celia Martin Bravo, Isabel Blancas López-Barajas, Raúl Quirós López, Marta Robles Lasarte, Rosa Villatoro Roldán, Julia Alcaide García, et al. (+10)
453 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S05-03: Preserving innate memory to overcome SARS-CoV-2 infection through the mevalonate pathway Juan Luis Gomez, Adam Brufsky
454 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-049: SARS-CoV-2 multiepitope vaccine constructs designed to drive long-term immunity in the majority of the population Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris
455 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-075: Performance comparison of five extraction kits for SARS-CoV-2 RNA extraction Ilinca M. Lungu, Angela De Luca, Jason Li, Jane Bayani, Melanie Spears, Trevor J. Pugh, John M.S. Bartlett
456 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S08-01: Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing Chenyu Li, David N. Debruyne, Julia Spencer, Vidushi Kapoor, Lily Y. Liu, Bo Zhou, et al. (+19)
457 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S03-03: A computational approach to identify a possible SARS-CoV-2 vaccine from receptor binding domain peptide sequence on spike glycoproteins Majid Al-Zahrani
458 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S03-02: Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T-cell epitopes Asaf Poran, Dewi Harjanto, Matt Malloy, Christina M. Arieta, Daniel A. Rothenberg, Divya Lenkala, et al. (+5)
459 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-043: A prospective testing SARS-Cov-2/COVID-19 in cancer patients with antitumor treatment Kathan D. Mehta, Elizabeth Wulf-Burchfield, Natalie Streeter, Anup Kasi, Adam H. AlDouri, Roy Jensen, et al. (+3)
460 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-018: Hematology oncology COllaborative VIDeoconferencing (COVID) Learning Initiative: A multi-institutional trainee alliance to rapidly disseminate emerging SARS-CoV2 and cancer best practices Richard L. Martin, Michael Grant, Rushad Patell, Shonali Middha, Jori May, Charles Bodine, et al. (+7)
461 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Dec―03 Abstract PO-032: Virtually SPARCC-ing clinical cancer careers among URM students during a global pandemic Kristina Kaljo, Robert Treat, Janet S. Rader
462 [GO] Clinical Cancer Research 2020―Dec―03 Abstract S07-03: Scientia potentia est: How the Italian world of oncology changes in the COVID19 pandemic Zelmira Ballatore, Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, et al. (+4)
463 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-006: Barriers to Virtual Video Connect (VVC) cancer care among southern rural veterans during the COVID19 pandemic Philip A. Haddad, Dalia Hammoud, Michelle Phelan, Rosline Wallace-Seamster, Kevin Gallagher
464 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-039: Technology-mediated communication with patients is a challenge for oncologists in the digital and pandemic era… and the winner is WhatsApp! Mariangela Torniai, Giulia Marcantognini, Ilaria Fiordoliva, Giulia Mentrasti, Veronica Agostinelli, Alessandra Pagliacci, et al. (+2)
465 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-072: Doctors and nurses during COVID19 pandemic: A different perception of cancer care Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, Alessandra Lucarelli, et al. (+2)
466 [GO] Clinical Cancer Research 2020―Dec―03 Abstract PO-010: Changes in lung cancer treatment as a result of the COVID19 pandemic: A prospective observational study Suzanne Kazandjian, Nathaniel Bouganim, Arielle Elkrief
467 [GO] Blood Cancer Discovery 2020―Nov―04 Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, et al. (+24)
468 [GO] Blood Cancer Discovery 2020―Nov―02 Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19 Madhav V. Dhodapkar, Kavita M. Dhodapkar, Rafi Ahmed
469 [GO] Clinical Cancer Research 2020―Oct―13 Similarities in Risk for COVID-19 and Cancer Disparities Lisa Newman, Robert A Winn, John M. Carethers
470 [GO] Blood Cancer Discovery 2020―Oct―13 Don't Compromise Myeloma Care Due to COVID-19 Pandemic! Nikhil C. Munshi, Kenneth C. Anderson
471 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Sep―25 Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey Jessica Y Islam, Marlene Camacho-Rivera, Denise C. Vidot
472 [GO] Cancer Prevention Research 2020―Sep―21 COVID-19, Cancer Care and Prevention Raymond N. DuBois
473 [GO] Cancer Discovery 2020―Sep―18 Repurposing Cancer Drugs for COVID-19
474 [GO] Cancer Prevention Research 2020―Sep―17 Disparities in Cancer Prevention in the COVID-19 Era John M. Carethers, Rajarshi Sengupta, Rea Blakey, Antoni Ribas, Gypsyamber D'Souza
475 [GO] Cancer Discovery 2020―Sep―16 Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers
476 [GO] Cancer Research 2020―Sep―04 Abstract CT405: Experience in using oncology drugs in patients with COVID-19 Paolo A. Ascierto
477 [GO] Cancer Research 2020―Sep―04 Abstract CT402: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion): First results of a global collaboration to address the impact of COVID-19 in patients with thoracic malignancies Marina Chiara Garassino
478 [GO] Cancer Research 2020―Sep―04 Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments Fabrice Barlesi, Stéphanie Foulon, Arnauld Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, et al. (+12)
479 [GO] Cancer Research 2020―Sep―04 Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak Meng-Yuan Dai, Dian-bo Liu, Miao Liu, Fu-Xiang Zhou, Gui-Ling Li, Zhen Chen, et al. (+32)
480 [GO] Cancer Research 2020―Sep―04 Abstract CT401: The experience of treating patients with cancer during the COVID-19 pandemic in China Li Zhang, F Zhu, L Xie, C Wang, J Wang, R Chen, et al. (+12)
481 [GO] Cancer Discovery 2020―Sep―01 COVID-19 Challenges Status Quo for Cancer Care
482 [GO] Cancer Discovery 2020―Aug―19 ICI Impact on COVID-19 Severity Modest at Best
483 [GO] Clinical Cancer Research 2020―Aug―18 The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3)
484 [GO] Blood Cancer Discovery 2020―Jul―31 COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, Dhwani Patel, Eric L Smith, Neha Korde, et al. (+24)
485 [GO] Cancer Discovery 2020―Jul―31 Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58)
486 [GO] Cancer Discovery 2020―Jul―22 Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39)
487 [GO] Cancer Discovery 2020―Jul―15 Cancer Research: The lessons to learn from COVID-19 Chris Bailey, James R M Black, Charles Swanton
488 [GO] Clinical Cancer Research 2020―Jul―02 COVID-19 testing in cancer patients: Does one size fit all? Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3)
489 [GO] Clinical Cancer Research 2020―Jun―15 Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6)
490 [GO] Cancer Discovery 2020―Jun―08 COVID-19 Delays Cancer Screenings
491 [GO] Clinical Cancer Research 2020―Jun―05 The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. Fatima Karzai, Ravi A. Madan, William Dahut
492 [GO] Cancer Discovery 2020―May―29 Registries Offer Insights on COVID-19-Cancer Connection
493 [GO] Cancer Discovery 2020―May―22 The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan
494 [GO] Cancer Discovery 2020―May―13 The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research Tobias Janowitz, David A. Tuveson
495 [GO] Cancer Discovery 2020―May―12 Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann
496 [GO] Cancer Discovery 2020―May―05 Cytokine Storm Drugs Move from CAR T to COVID-19
497 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―May―05 The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action Andrew T. Chan, David A. Drew, Long H. Nguyen, Amit D. Joshi, Wenjie Ma, Chuan-Guo Guo, et al. (+54)
498 [GO] Cancer Discovery 2020―May―01 Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13)
499 [GO] Cancer Discovery 2020―Apr―28 Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32)
500 [GO] Cancer Discovery 2020―Apr―24 COVID-19 Hits Cancer Research Funding
501 [GO] Cancer Discovery 2020―Apr―20 COVID-19 More Frequent, Severe in Cancer Patients
502 [GO] Clinical Cancer Research 2020―Apr―20 Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic Aaron C Tan, David M Ashley, Mustafa Khasraw
503 [GO] Cancer Discovery 2020―Apr―17 Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients Sangya Agarwal, Carl H. June
504 [GO] Cancer Discovery 2020―Apr―15 AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic
505 [GO] Cancer Discovery 2020―Apr―10 Cancer Care Goes Virtual in Response to COVID-19
506 [GO] Cancer Discovery 2020―Apr―10 TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff
507 [GO] Cancer Discovery 2020―Apr―01 Clinical Research Slows as COVID-19 Surges
508 [GO] Cancer Discovery 2020―Mar―31 Cancer Labs Pivot to Battle COVID-19
509 [GO] Cancer Discovery 2020―Mar―24 COVID-19 Challenges Basic Researchers
 [1] 

509 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.114 sec